‘AeroNabs’ Promise Powerful, Inhalable Protection Against COVID-19
UCSF scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.
University of California San Francisco
Give to UCSF
‘Wasabi Receptor’ Reveals Its Eye-Watering Secrets
UCSF researchers have now determined how the TRPA1 molecule manages to sense such a diverse variety of dangerous chemicals – and do so with enough sensitivity to let you flee before suffering too much tissue damage.
COVID-19 Frontliners: the Stem Cell Biologist
Why are more men than women dying of COVID-19? Scientist Faranak Fattahi, PhD, has found a clue.
Two Projects Using Hydrogel Biomaterials to Stimulate Tissue Regeneration Move Forward with New Funding
Two innovative UCSF projects in hydrogel therapies to develop new salivary glands and restore muscle loss after facial injuries have received critical funding to move closer to clinical trials.
1 in 3 Young Adults May Face Severe COVID-19, UCSF Study Shows
The researchers determined "medical vulnerability" by referencing indicators identified by the CDC, including heart conditions, diabetes, current asthma, immune conditions (such as lupus, gout, rheumatoid arthritis), liver conditions, obesity and smoking within the previous 30 days. Additionally, the researchers added e-cigarettes to tobacco and cigar use.
Largest-Ever Study of Prostate Cancer Genomics in Black Men IDs Potential Targets for Precision Therapies
None of the individual tumor genetic differences that were identified are likely to explain significant differences in health outcomes or to prevent Black Americans from benefiting from a new generation of precision prostate cancer therapies, researchers say, as long as the therapies are applied equitably.
New Model of Breast Cancer’s Causes Developed by UCSF-led Team
A new model of the causes of breast cancer, created by a team led by researchers at UCSF, Genentech and Stanford University, is designed to capture the complex interrelationships between dozens of primary and secondary breast cancer causes and stimulate further research.
Recombinant Antibody Network Partners with Bristol Myers Squibb to Develop Novel Therapies
Under a new agreement, Celgene will further invest in the RAN’s state-of-the-art antibody engineering program to expand target discovery from oncology and immunology to include neurology.
UCSF, St. Jude Identify Key Culprit Driving Treatment Resistance in Deadly Immune Disorder
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
Pregnant Women with Fatty Liver Disease Face Worse Outcomes
Pregnant women with the metabolic condition known as non-alcoholic fatty liver disease have more than four times the risk of serious adverse maternal-fetal outcomes.
Tumors Disrupt the Immune System Throughout the Body
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
UCSF Cancer Researchers Present New Advances at ASCO 2020
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
How a Key Protein Juggles Multiple Demands to Keep Neurons Firing
UCSF researchers have become to the first to solve the structure of a hard-working protein that helps reload neurons for repeated firing.
Smoking Nearly Doubles the Rate of COVID-19 Progression
Smoking significantly worsens COVID-19, according to a new analysis by UCSF of the association between smoking and progression of the infectious disease.
